Article Text

Download PDFPDF

93 Unexplained pulmonary hypertension in black women living with hiv (BWLWH): H-art to heart sub-study
  1. Gavin Manmathan1,
  2. Nnenna Ngwu2,
  3. James Johnson2,
  4. Nargis Hemat2,
  5. Liza Chacko3,
  6. Callum Little3,
  7. Tristan Barber2,
  8. Sabine Kinloch3,
  9. Sara Madge2,
  10. Tushar Kotecha3,
  11. Fiona Burns2,
  12. Margaret Johnson2,
  13. Roby Rakhit3
  1. 1Royal Free London NHS Foundation Trust
  2. 2Royal Free Hospital
  3. 3University College London


Introduction 37.9 million people worldwide are living with HIV (human immunodeficiency virus), acquired immune deficiency syndrome (AIDS)-related deaths have reduced by 51% since the peak in 2004. 42% of those infected are BWLWH yet represent only 9% of those included in clinical trials.

HIV/AIDS has been shown to be associated with the development of heart failure, pulmonary hypertension and myocarditis. Previous studies in asymptomatic PLWH have revealed a high burden of underlying CVD and subclinical myocardial inflammation as detected by CMR.

The H-ART to Heart study is designed to examine the burden of cardiovascular disease (CVD) in asymptomatic PLWH compared to HIV negative controls (-) excluding traditional CV risk factors.

Methods A cross-sectional study comparing asymptomatic BWLWH aged 35-55yrs (diagnosed >10 yrs, with undetectable viral loads) to HIV negative controls. Black African/Caribbean women without known CV risk factors (hypertension, hyperlipidaemia, diabetes, smoking, inflammatory arthritis, depression, severe mental illness) or hepatitis co-infection were included.

Assessment included blood pressure (BP), bloods including NT-ProBNP. Echocardiography was performed in all participants and stress perfusion CMR with multiparametric mapping for BWLWH. We compared CMR results with a previously selected control group.

Results 48 participants have been recruited (23 BWLWH,25 controls; mean age 47.7±4.1 v 44.7±6.2yrs, P=0.06; mean BP 125/77 v 123/79mmHg), mean results for BWLWH were as follows: duration of HIV 17.6±6.2 yrs, duration of ART 11.5±5.2 yrs, nadir CD4 count 262±158 cells/μL, current CD4 count 662±188 cells/μL and current viral load <40 copies/mL . There were no significant differences in baseline data (Table 1) apart from higher mean cLDL (3.49±1.22 v 2.42±0.74, p=0.02) and median CRP (3(2,6) v 1(1,3), p=0.042) in BWLWH, as well as a trend towards higher median NT-proBNP (147 (108,153) v 65.5(59.5,73.8)ng/L). Echocardiogram parameters were similar between groups, however there was a trend to higher LA volumes in BWLWH (48.16±10.09 v 42.09±11.56, p=0.126) and similar prevalence of detectable tricuspid regurgitation leading to a significantly elevated estimated Pulmonary Artery Pressure (PAP) in BWLWH (27.7 v 21.2mmHg, p=0.016). Interestingly BWLWH had higher mean LVEF%(Simpson’s Biplane) than controls (Table 1).

A MRI sub-study data showed no difference in LV mass, LVEDV, T1, T2 with no evidence of ischaemia or myocarditis between the groups, although number are small (Table 2).

Abstract 93 Table 1 Baseline characteristics and average results by group for inflammatory and heart failure biomarker (NT-ProBNP) and echocardiography. Mean average data is displayed ± SD, median (IQ1,IQ3). Student t-test for parametric data, with Z-Test for proportions
Abstract 93 Table 2 Perfusion CMR data averaged results by groups. Mean average data is displayed ± SD (number of participants) apart from LGE where number of positive tests (percentage) is expressed. Student t-test for parametric data, with Z-Test for proportions

Conclusion Preliminary data from our study of asymptomatic low risk BWLWH without traditional CVD risk factors removed indicates raised PAP which cannot be explained by hypertension, diastolic dysfunction, ischaemia or previous myocarditis. The cause of the raised PAP is unclear and requires further investigation. Whether this finding is of importance in CV risk assessment of BWLWH remains to be seen.

Conflict of Interest None

  • HIV
  • Pulmonary Hypertension
  • Echocardiography

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.